Galera
Discovering and developing novel mechanism-based therapies that have the potential to improve both treatment and outcomes for patients with cancer. Learn more
Launch date
Employees
Market cap
AUD5.7m
Enterprise valuation
(AUD9m) (Public information from Sep 2024)
Share price
$0.079 GRTX
Malvern Pennsylvania (HQ)
Authorizing premium user...